Herder, Christian http://orcid.org/0000-0002-2050-093X
Roden, Michael http://orcid.org/0000-0001-8200-6382
Venteclef, Nicolas
Article History
Received: 1 February 2024
Revised: 26 February 2024
Accepted: 28 February 2024
First Online: 13 March 2024
Competing interests
: C.H. and N.V. reported no conflicts of interest. M.R. received personal fees from Allergan, Astra-Zeneca, Boehringer-Ingelheim, Echosens, Lilly, Gilead Sciences, Madrigal, MSD, Novo Nordisk, Pfizer and Target RWE as well as investigator-initiated research support from Boehringer-Ingelheim, Nutricia/Danone and Sanofi-Aventis.